Stevanato Group S.p.A. (STVN) Stock

Healthcare · Medical Instruments & Supplies · Member of Other US Stocks

Stevanato Group S.p.A. (STVN) closed at USD 19.25 on 2026-10-15, a change of -25.1 % over the past year, with a market capitalization of USD 5.16B.

Stevanato Group S.p.A. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Stevanato Group S.p.A. key figures

Previous close

USD 19.25 (2026-10-15)

1-year change

-25.1 %

Market cap

USD 5.16B

Enterprise value

USD 5.53B

P/E ratio (trailing)

33.16

P/E ratio (forward)

22.84

EPS (trailing)

0.57

EPS (forward)

0.83

PEG ratio

1.37

Price to book

2.97

Revenue growth

7.8 %

Earnings growth

-26.5 %

Dividend per share (trailing)

0.00

Short ratio

3.53

Employees

6,010

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Stevanato Group S.p.A.

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Stevanato Group S.p.A. and compare it with other stocks.